Related references
Note: Only part of the references are listed.Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection
John A. Kellum et al.
CRITICAL CARE MEDICINE (2021)
Mortality and serum hepcidin are associated with persistent and transient acute kidney injury in septic patients
Ze-Liang Qiu et al.
CLINICAL NEPHROLOGY (2021)
Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Elizabeta Nemeth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Hepcidin-25 as a Novel Kidney Biomarker for Cardiac Surgery-Associated Acute Kidney Injury
Sun Young Cho et al.
ANNALS OF LABORATORY MEDICINE (2021)
Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer
Ching-Ting Wei et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells
Andrew J. Schwartz et al.
NATURE METABOLISM (2021)
Identifying the Patient at Risk for Acute Kidney Injury: Pediatric Sepsis Biomarker Risk Model Study
Jason Gien et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity
William E. Ruff et al.
CELL HOST & MICROBE (2019)
Plasma and urine Neutrophil Gelatinase Associated Lipocalin (NGAL) levels as markers of kidney injury in critically ill children at Kenyatta National Hospital (Nairobi)
P. Kiptima et al.
CLINICA CHIMICA ACTA (2019)
Protective Role of Hepcidin in Polymicrobial Sepsis and Acute Kidney Injury
Yogesh Scindia et al.
FRONTIERS IN PHARMACOLOGY (2019)
Hepcidin - Potential biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions
Jolanta Malyszko et al.
ADVANCES IN MEDICAL SCIENCES (2019)
Urinary neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury in sepsis patients in the emergency department
Hee Su Park et al.
CLINICA CHIMICA ACTA (2019)
Iron Homeostasis in Healthy Kidney and its Role in Acute Kidney Injury
Yogesh Scindia et al.
SEMINARS IN NEPHROLOGY (2019)
Sepsis associated acute kidney injury
Jason T. Poston et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients
Itir Yegenaga et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2018)
Pre-operative anaemia, intra-operative hepcidin concentration and acute kidney injury after cardiac surgery: a retrospective observational study
K. Karkouti et al.
ANAESTHESIA (2018)
Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury
Sundararaman Swaminathan
NEPHRON (2018)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Determinants of hepcidin levels in sepsis-associated acute kidney injury: Impact on pAKT/PTEN pathways?
Mona F. Schaalan et al.
JOURNAL OF IMMUNOTOXICOLOGY (2016)
Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis
An Zhang et al.
CRITICAL CARE (2016)
Hepatic Hepcidin Protects against Polymicrobial Sepsis in Mice by Regulating Host Iron Status
CongLi Zeng et al.
ANESTHESIOLOGY (2015)
Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury
Xingui Dai et al.
CRITICAL CARE (2015)
Hepcidin Induction by Pathogens and Pathogen-Derived Molecules Is Strongly Dependent on Interleukin-6
Richard Rodriguez et al.
INFECTION AND IMMUNITY (2014)
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome
Esther Zipperer et al.
ANNALS OF HEMATOLOGY (2013)
Iron metabolism in the pathogenesis of iron-induced kidney injury
A. M. F. Martines et al.
NATURE REVIEWS NEPHROLOGY (2013)
Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass
John R. Prowle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice
Ying-Hsien Huang et al.
PEPTIDES (2012)
Hepcidin and the Iron-Infection Axis
Hal Drakesmith et al.
SCIENCE (2012)
Urine albumin as a biomarker in acute kidney injury
Subhashini Bolisetty et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Urinary hepcidin: an inverse biomarker of acute kidney injury after cardiopulmonary bypass?
John R. Prowle et al.
CURRENT OPINION IN CRITICAL CARE (2010)
Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness
Sean M. Bagshaw et al.
INTENSIVE CARE MEDICINE (2010)
Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes
Sean M. Bagshaw et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Dual action of neutrophil gelatinase-associated lipocalin
Kai M. Schmidt-Ott et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
J Mishra et al.
LANCET (2005)
Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro
JA Gwira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney
H Kulaksiz et al.
JOURNAL OF ENDOCRINOLOGY (2005)
Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury
J Mishra et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
E Nemeth et al.
BLOOD (2003)
An iron delivery pathway mediated by a lipocalin
J Yang et al.
MOLECULAR CELL (2002)
Share Paper
